A few days ago, Scott Gottlieb, head of FDA, provided a 40 minute speech and Q&A session oriented to drug development at the annual RAPS converence. For summary and links to Youtube, see Endpoints (here). (For text of his full speech, here.)
Gottlieb noted he would be speaking on the FDA's pathway to improving device regulation soon. See him at the October 3, 2017, Medical Device Innovation Consortum (MDIC) forum in Washington, DC. The organization is quite active (homepage here) and the full agenda and registration details are online here. Jeff Shuren, head of CDRH, will also present at the conference.